Skip to Main Content

Author Details

Julie A Hong
National Cancer Institute, National Institutes of Health
2001
39
24
PMIDPaper TitleJournal TitlePublished Year
37023402Neutron Capture Therapy: The Promise of Novel Agents and Medical Facility-Based Neutron Sources.Cancer Biother Radiopharm2023
37023402Neutron Capture Therapy: The Promise of Novel Agents and Medical Facility-Based Neutron Sources.Cancer Biother Radiopharm2023
37541280National Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: challenges and recommended priorities.Lancet Oncol2023
37541280National Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: challenges and recommended priorities.Lancet Oncol2023
35245101Tumor Heterogeneity Research and Innovation in Biologically Based Radiation Therapy From the National Cancer Institute Radiation Research Program Portfolio.J Clin Oncol2022
35976726The State of Preclinical Modeling for Early Phase Cancer Trials Using Molecularly Targeted Agents with Radiation.Radiat Res2022
35245101Tumor Heterogeneity Research and Innovation in Biologically Based Radiation Therapy From the National Cancer Institute Radiation Research Program Portfolio.J Clin Oncol2022
35976726The State of Preclinical Modeling for Early Phase Cancer Trials Using Molecularly Targeted Agents with Radiation.Radiat Res2022
32927122UHRF1 Is a Novel Druggable Epigenetic Target in Malignant Pleural Mesothelioma.J Thorac Oncol2021
34350377Moving Forward in the Next Decade: Radiation Oncology Sciences for Patient-Centered Cancer Care.JNCI Cancer Spectr2021
33548337FLASH Radiation Therapy: New Technology Plus Biology Required.Int J Radiat Oncol Biol Phys2021
32927122UHRF1 Is a Novel Druggable Epigenetic Target in Malignant Pleural Mesothelioma.J Thorac Oncol2021
34430349Randomized phase II trial of a first-in-human cancer cell lysate vaccine in patients with thoracic malignancies.Transl Lung Cancer Res2021
34378064National Cancer Institute support for targeted alpha-emitter therapy.Eur J Nucl Med Mol Imaging2021
33548337FLASH Radiation Therapy: New Technology Plus Biology Required.Int J Radiat Oncol Biol Phys2021
34378064National Cancer Institute support for targeted alpha-emitter therapy.Eur J Nucl Med Mol Imaging2021
34430349Randomized phase II trial of a first-in-human cancer cell lysate vaccine in patients with thoracic malignancies.Transl Lung Cancer Res2021
34350377Moving Forward in the Next Decade: Radiation Oncology Sciences for Patient-Centered Cancer Care.JNCI Cancer Spectr2021
31175181Severe Hepatotoxicity of Mithramycin Therapy Caused by Altered Expression of Hepatocellular Bile Transporters.Mol Pharmacol2019
31175181Severe Hepatotoxicity of Mithramycin Therapy Caused by Altered Expression of Hepatocellular Bile Transporters.Mol Pharmacol2019
29228209CD38 knockout suppresses tumorigenesis in mice and clonogenic growth of human lung cancer cells.Carcinogenesis2018
29228209CD38 knockout suppresses tumorigenesis in mice and clonogenic growth of human lung cancer cells.Carcinogenesis2018
29776293Analysis of circulating tumor DNA: The next paradigm shift in detection and treatment of lung cancer.J Thorac Cardiovasc Surg2018
29776293Analysis of circulating tumor DNA: The next paradigm shift in detection and treatment of lung cancer.J Thorac Cardiovasc Surg2018
28935813ASXL3 Is a Novel Pluripotency Factor in Human Respiratory Epithelial Cells and a Potential Therapeutic Target in Small Cell Lung Cancer.Cancer Res2017
28935813ASXL3 Is a Novel Pluripotency Factor in Human Respiratory Epithelial Cells and a Potential Therapeutic Target in Small Cell Lung Cancer.Cancer Res2017
26459178Mithramycin Depletes Specificity Protein 1 and Activates p53 to Mediate Senescence and Apoptosis of Malignant Pleural Mesothelioma Cells.Clin Cancer Res2016
26459178Mithramycin Depletes Specificity Protein 1 and Activates p53 to Mediate Senescence and Apoptosis of Malignant Pleural Mesothelioma Cells.Clin Cancer Res2016
25703328Cigarette smoke mediates epigenetic repression of miR-217 during esophageal adenocarcinogenesis.Oncogene2015
25703328Cigarette smoke mediates epigenetic repression of miR-217 during esophageal adenocarcinogenesis.Oncogene2015
26298164Pulmonary Metastases Exhibit Epigenetic Clonality: Implications for Precision Cancer Therapy.Ann Thorac Surg2015
26298164Pulmonary Metastases Exhibit Epigenetic Clonality: Implications for Precision Cancer Therapy.Ann Thorac Surg2015
24983628Telomerase variant A279T induces telomere dysfunction and inhibits non-canonical telomerase activity in esophageal carcinomas.PLoS One2014
24983628Telomerase variant A279T induces telomere dysfunction and inhibits non-canonical telomerase activity in esophageal carcinomas.PLoS One2014
23426183Cigarette smoke mediates epigenetic repression of miR-487b during pulmonary carcinogenesis.J Clin Invest2013
23426183Cigarette smoke mediates epigenetic repression of miR-487b during pulmonary carcinogenesis.J Clin Invest2013
22028491Polycomb repressor complex-2 is a novel target for mesothelioma therapy.Clin Cancer Res2012
22751465Mithramycin represses basal and cigarette smoke-induced expression of ABCG2 and inhibits stem cell signaling in lung and esophageal cancer cells.Cancer Res2012
22028491Polycomb repressor complex-2 is a novel target for mesothelioma therapy.Clin Cancer Res2012
22751465Mithramycin represses basal and cigarette smoke-induced expression of ABCG2 and inhibits stem cell signaling in lung and esophageal cancer cells.Cancer Res2012
21602888Inactivation of the von Hippel-Lindau tumor suppressor leads to selective expression of a human endogenous retrovirus in kidney cancer.Oncogene2011
21602888Inactivation of the von Hippel-Lindau tumor suppressor leads to selective expression of a human endogenous retrovirus in kidney cancer.Oncogene2011
21546573Inhibition of histone lysine methylation enhances cancer-testis antigen expression in lung cancer cells: implications for adoptive immunotherapy of cancer.Cancer Res2011
21546573Inhibition of histone lysine methylation enhances cancer-testis antigen expression in lung cancer cells: implications for adoptive immunotherapy of cancer.Cancer Res2011
20440268Epigenomic alterations and gene expression profiles in respiratory epithelia exposed to cigarette smoke condensate.Oncogene2010
21048943Cigarette smoke induces C/EBP-β-mediated activation of miR-31 in normal human respiratory epithelia and lung cancer cells.PLoS One2010
20440268Epigenomic alterations and gene expression profiles in respiratory epithelia exposed to cigarette smoke condensate.Oncogene2010
21048943Cigarette smoke induces C/EBP-β-mediated activation of miR-31 in normal human respiratory epithelia and lung cancer cells.PLoS One2010
18677478Recognition of NY-ESO-1+ tumor cells by engineered lymphocytes is enhanced by improved vector design and epigenetic modulation of tumor antigen expression.Cancer Immunol Immunother2009
19351856Tobacco smoke induces polycomb-mediated repression of Dickkopf-1 in lung cancer cells.Cancer Res2009
  • 1 - 50 of 78

Recommended Authors

Jyoti Malhotra
Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School
Career Start Year 2012
Number of shared co-authors 0
Siddhartha Devarakonda
Siteman Cancer Center, Washington University School of Medicine
Career Start Year 2011
Number of shared co-authors 0
Daniel D De Carvalho
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2010
Number of shared co-authors 0
Larissa A Pikor
Ottawa Hospital Research Institute
Career Start Year 2010
Number of shared co-authors 0
Chad V Pecot
University of North Carolina at Chapel Hill
Career Start Year 2009
Number of shared co-authors 0
Wei Zhang
Montefiore Medical Center
Career Start Year 2008
Number of shared co-authors 0
John T Poirier
Laura and Isaac Perlmutter Cancer Center
Career Start Year 2007
Number of shared co-authors 0
Anderly C Chueh
Biomedicine Discovery Institute, Monash University
Career Start Year 2005
Number of shared co-authors 0
Lixia Diao
The University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 0
Elena Ivanova
Dana-Farber Cancer Institute
Career Start Year 2003
Number of shared co-authors 0
Xiaohu Zhang
National Center for Advancing Translational Sciences
Career Start Year 2003
Number of shared co-authors 8
Trudy G Oliver
Duke University
Career Start Year 2003
Number of shared co-authors 1
Zhuo Chen
The First Hospital of Lanzhou University
Career Start Year 2002
Number of shared co-authors 0
Eddy S Yang
University of Alabama at Birmingham, O'Neal Comprehensive Cancer Center
Career Start Year 1999
Number of shared co-authors 0
David Neil Hayes
Center for Cancer Research, University of Tennessee Health Science Center
Career Start Year 1999
Number of shared co-authors 2
Joyce E Ohm
Roswell Park Comprehensive Cancer Center
Career Start Year 1999
Number of shared co-authors 0
Ranjit S Bindra
Yale University School of Medicine
Career Start Year 1997
Number of shared co-authors 2
Peter S Hammerman
Novartis Institutes for BioMedical Research
Career Start Year 1996
Number of shared co-authors 0
Jorge Nieva
Norris Comprehensive Cancer Center, University of Southern California
Career Start Year 1995
Number of shared co-authors 1
Timothy A Chan
Cleveland Clinic.
Career Start Year 1994
Number of shared co-authors 4
David N Watkins
Research Institute in Oncology and Hematology
Career Start Year 1991
Number of shared co-authors 0
E Alejandro Sweet-Cordero
University of California San Francisco
Career Start Year 1989
Number of shared co-authors 3
Charles M Rudin
Memorial Sloan Kettering Cancer Center
Career Start Year 1989
Number of shared co-authors 2
Matthew Meyerson
Broad Institute
Career Start Year 1983
Number of shared co-authors 3
Helen J Ross
Mayo Clinic
Career Start Year 1982
Number of shared co-authors 0
David M Jablons
University of California, USA Cardiovascular Research Institute san francisco
Career Start Year 1981
Number of shared co-authors 2
Giuseppe Giaccone
Meyer Cancer Center
Career Start Year 1981
Number of shared co-authors 19
Ramaswamy Govindan
Siteman Cancer Center, Washington University School of Medicine
Career Start Year 1981
Number of shared co-authors 2
Ming-Sound Tsao
University Health Network, University of Toronto
Career Start Year 1972
Number of shared co-authors 2
John D Minna
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1967
Number of shared co-authors 2

Collaborators

David S Schrump
Center for Cancer Research, National Cancer Institute
Co-authored papers 32
Mary Zhang
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 14
Mahadev Rao
Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences
Co-authored papers 10
Sichuan Xi
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 9
Michael Graham Espey
National Cancer Institute, National Institutes of Health
Co-authored papers 5
Emily S Reardon
Center for Cancer Research National Cancer Institute, National Institutes of Health
Co-authored papers 4
Fang Liu
Chengdu Military General Hospital
Co-authored papers 4
Markku Miettinen
National Cancer Institute
Co-authored papers 4
Maocheng Yang
College of Basic Medicine, Army Medical University
Co-authored papers 4
Yuwei Zhang
Thoracic and GI Oncology Branch National Cancer Institute
Co-authored papers 4
Raphael Bueno
Co-authored papers 3
Paul S Meltzer
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 3
Seth M Steinberg
Center for Cancer Research, National Cancer Institute
Co-authored papers 3
Vivek Shukla
Chalmers University of Technology
Co-authored papers 3
Patricia Fetsch
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 3
Zied Abdullaev
Co-authored papers 2
Cuong Hoang-Vu
Center for Cancer Research, National Cancer Institute
Co-authored papers 2
Maria J Merino
National Cancer Institute, National Institutes of Health
Co-authored papers 2
J. Carl Barrett
Oncology R&D
Co-authored papers 2
Nasser K Altorki
New York-Presbyterian Hospital
Co-authored papers 2
Susan R Davis
Co-authored papers 2
Sean Davis
Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington
Co-authored papers 2
Mustafa Hussain
University of Chicago Medical Center
Co-authored papers 2
Thomas Ried
Center for Cancer Research, National Cancer Institute
Co-authored papers 2
Robert L Walker
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Eden C Payabyab
Center for Cancer Research National Cancer Institute, National Institutes of Health
Co-authored papers 2
Danny Wangsa
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Steven A Rosenberg
University of Colorado School of Medicine
Co-authored papers 2
Nicholas P Restifo
National Cancer Institute, National Institutes of Health (NIH)
Co-authored papers 2
Sandra Burkett
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
Release 1.2